195 related articles for article (PubMed ID: 36779131)
1. Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer.
Yamazoe M; Hatakeyama T; Furukawa K; Kato K; Horiuchi K
Cureus; 2023 Jan; 15(1):e33557. PubMed ID: 36779131
[TBL] [Abstract][Full Text] [Related]
2. Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.
Kunii E; Owaki S; Yamada K; Yoshihara M; Yamaba Y; Takakuwa O; Toyoda T; Akita K
Intern Med; 2022 Jun; 61(11):1739-1742. PubMed ID: 34707051
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome.
Ishibashi N; Tabata T; Nonomura R; Oshima Y; Sasaki T; Mitomo H; Sugawara T; Sagawa M
Respir Med Case Rep; 2024; 47():101974. PubMed ID: 38374927
[TBL] [Abstract][Full Text] [Related]
4. Durvalumab for Extensive-Stage of Small-Cell Lung Cancer With Lambert-Eaton Myasthenic Syndrome.
Machiyama H; Minami S
J Med Cases; 2023 Feb; 14(2):71-75. PubMed ID: 36896371
[TBL] [Abstract][Full Text] [Related]
5. Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer.
Takigawa Y; Watanabe H; Omote Y; Kurihara S; Inoue T; Fujiwara M; Mitsumune S; Onishi K; Kudo K; Sato A; Sato K; Fujiwara K; Shibayama T
Intern Med; 2023 Apr; 62(7):1055-1058. PubMed ID: 36047125
[TBL] [Abstract][Full Text] [Related]
6. Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer.
Nakatani Y; Tanaka N; Enami T; Minami S; Okazaki T; Komuta K
Case Rep Neurol; 2018; 10(3):346-352. PubMed ID: 30627102
[TBL] [Abstract][Full Text] [Related]
7. Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer.
Agrawal K; Agrawal N
Case Rep Neurol Med; 2019; 2019():5353202. PubMed ID: 31355029
[TBL] [Abstract][Full Text] [Related]
8. Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.
Zhang RR; Han T; Guo F; Liu ZZ; Han YL; Chen WC; Liu YY; Xie XD
Oncol Lett; 2015 Sep; 10(3):1339-1342. PubMed ID: 26622673
[TBL] [Abstract][Full Text] [Related]
9. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
10. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome with anti-acetylcholine receptor antibody and anterior mediastinal tumor.
Matsumoto H; Ohtomo G; Akahori T; Hashida H
J Gen Fam Med; 2017 Oct; 18(5):282-284. PubMed ID: 29264043
[TBL] [Abstract][Full Text] [Related]
12. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
15. [A case of cT0N2M0 small cell lung cancer with Lambert-Eaton myasthenic syndrome].
Tsukiji J; Kaneko T; Saito H; Kobayashi M; Kakemizu N; Komatsu S; Nishiyama H; Amano H; Miura K; Satoh T; Shinohara T; Mishima W; Yamakawa Y; Nishihira R; Miyashita A; Noda K; Ishigatsubo Y; Matsuse T
Nihon Kokyuki Gakkai Zasshi; 2004 Sep; 42(9):820-4. PubMed ID: 15500150
[TBL] [Abstract][Full Text] [Related]
16. Voltage gated calcium channel antibody-related neurological diseases.
Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H
Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study.
Lee JH; Baek SK; Han JJ; Kim HJ; Lee YA; Yoo D; Maeng CH
J Chemother; 2023 May; 35(3):275-280. PubMed ID: 35549636
[TBL] [Abstract][Full Text] [Related]
19. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
Motomura M; Iwanaga H
Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
[TBL] [Abstract][Full Text] [Related]
20. Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors.
Yamasaki H; Futamura N; Funakawa I; Kohara N; Yoshimura S; Motomura M
Intern Med; 2022 Apr; 61(7):1063-1065. PubMed ID: 34544947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]